ABVX compared with IBRX: revenue, margins and what each company keeps, and the suppliers and customers both name

ABVXAbivax S.A.

Mkt capRevenueRevenue

IBRXImmunityBio, Inc.

Mkt capRevenueRevenue

Compare

ABVXAbivax S.A.

IBRXImmunityBio, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ABVX

No earnings history for ABVX.

IBRX

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±10.2%▼−2.80%×0.27

May 7 '26±6.7%▼−7.40%×1.10

Q1 FY26±5.5%▲+7.16%×1.31

Feb 23 '26±29.3%▲+12.99%×0.44

= impliedABVX realized, solidIBRX realized, hatchedOne scale, both sides: full bar = 30%× = |realized| ÷ impliedSource: market data

ABVXAbivax S.A.

84.73▼−2.15%· post 84.72· delayed

Mkt cap$6.0BRevenue—Revenue—

IBRXImmunityBio, Inc.

7.95▼−4.15%· post 7.99· delayed

After hoursNov 2 '26delayed

Mkt cap$8.8BRevenue$51MQ2 FY26Revenue$140MFY25

Compare

After hoursNov 2 '26delayed

ABVXAbivax S.A.

IBRXImmunityBio, Inc.

84.73▼−2.15%post 84.72delayed

Price

7.95▼−4.15%post 7.99delayed

$6.0B

Mkt cap

$8.8B

—

Revenue

$51MQ2 FY26

—

Revenue

$140MFY25

ABVX84.73▼−2.15%vsIBRX7.95▼−4.15%After hoursNov 2 '26delayed